Natixis Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $415K | Buy |
|
|||||
|
2025
Q2 | $316K | Buy |
|
|||||
|
2025
Q1 | $327K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $327K | Sell |
|
|||||
|
2024
Q1 | $345K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $481K | Buy |
|
|||||
|
2023
Q1 | $423K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $666K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $984K | Buy |
|
|||||
|
2021
Q4 | $633K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $2.32M | Buy |
|
|||||
|
2020
Q2 | $1.92M | Buy |
|
|||||
|
2020
Q1 | $718K | Buy |
|